SCHEMBL20151017

SCHEMBL20151017

c1ccc2c(c1)ccc1c3ccccc3n(-c3ccc(-c4ccc5c(c4)c4ccccc4n5-c4nc5ccccc5c5nc6ccccc6n45)cc3)c21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.41
HPGD P15428 6/20 0.41
ALDH1A1 P00352 5/20 0.41
KMT2A Q03164 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
MAPT P10636 4/20 0.39
LMNA P02545 1/20 0.39
TP53 P04637 1/20 0.39
POLB P06746 1/20 0.39
HSD17B10 Q99714 1/20 0.39
MEN1 O00255 2/20 0.37
GAA P10253 1/20 0.33
HIF1A Q16665 1/20 0.33
CAMKK1 Q8N5S9 2/20 0.32
CAMKK2 Q96RR4 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CASP1 P29466 1/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20151023 0.97 KDM4E (0.42) KDM4EHPGDALDH1A1KMT2ASMN1; SMN2
SCHEMBL20151041 0.95 KDM4E (0.43) KDM4EHPGDALDH1A1KMT2ASMN1; SMN2
SCHEMBL20151480 0.95 KDM4E (0.43) KDM4EHPGDALDH1A1KMT2ASMN1; SMN2
SCHEMBL20151479 0.95 HPGD (0.44) KDM4EHPGDALDH1A1KMT2ASMN1; SMN2
SCHEMBL20151179 0.94 HPGD (0.38) KDM4EHPGDALDH1A1KMT2ASMN1; SMN2
SCHEMBL20151033 0.93 KDM4E (0.40) KDM4EHPGDALDH1A1KMT2ASMN1; SMN2
SCHEMBL20151484 0.92 KDM4E (0.45) KDM4EHPGDALDH1A1KMT2ASMN1; SMN2
SCHEMBL20151052 0.92 KDM4E (0.42) KDM4EHPGDALDH1A1KMT2ASMN1; SMN2
SCHEMBL20151184 0.91 HPGD (0.39) KDM4EHPGDALDH1A1KMT2ASMN1; SMN2
SCHEMBL20151059 0.90 KDM4E (0.42) KDM4EHPGDALDH1A1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11031560-B2 Compound and organic electronic element comprising same LG CHEM, LTD. (KR) 2021-06-08 US disclosed
US-20180138422-A1 COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-17 US disclosed
US-20180138422-A1 COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11031560-B2 Compound and organic electronic element comprising same OR10J3, ESR1, ETV6 KDM4E 847/4885HPGD 4158/4885ALDH1A1 1081/4885
US-20180138422-A1 COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME OR10J3, ESR1, ETV6 KDM4E 847/4885HPGD 4158/4885ALDH1A1 1081/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.